R1 RCM Inc. (“R1”), a leader in technology-driven healthcare solutions, has been named a 2025 ‘Best in KLAS’ award winner in several key categories, underscoring its capabilities in revenue cycle ...

Private equity firms have locked in on revenue cycle management as a good investment opportunity as demand for the services ...

We recently published a list of 35 Non-Tech AI Opportunities Amid DeepSeek Selloff. In this article, we are going to take a ...

The RCM company's chairman, Vardhman Jain ... In 2024, New Mountain also unsuccessfully attempted to acquire R1 RCM. Private equity firms TowerBrook Capital Partners and Clayton, Dubilier ...

R1 RCM (NASDAQ:RCM) fell 2.4% in regular trading Thursday at least partly amid a downgrade of the company to neutral at Citi. Citi analyst Daniel Grosslight cut his rating to neutral from buy ...

The firm sought to buy out revenue cycle management vendor R1 RCM for $5.8 billion last year, though its offer was beat out when other investors took the company private in an $8.9 billion deal.

Nearly half of health systems and physician groups in the U.S. are behind on their 2022 revenue goals, and healthcare executives are worried about increasing costs, shrinking margins and the ...

In this article, we are going to take a look at where R1 RCM Inc. (NASDAQ:RCM) stands against the other AI stocks. In the third quarter of 2024, investment titan Blackrock released a commentary on ...

R1 RCM Inc. (NASDAQ:RCM ... There are multiple factors that make this company a promising investment avenue. To start with, the report for the third quarter of 2024 showed the company’s ability ...

In this article, we are going to take a look at where R1 RCM Inc. (NASDAQ:RCM) stands against other non-tech AI opportunities amid DeepSeek selloff. Investors are searching for safer ways to ...